Plasma amyloid β protein 1-42 levels in fetuses with Down syndrome

Early Human Development

Volumn 81, Issue 4, 2005, Pages 351-354

  Bartha, Jose L ^a,b   Soothill, Peter W ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Brain damage; Down syndrome; Plasma amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FETUS; FETUS BLOOD SAMPLING; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; KARYOTYPE; MATHEMATICAL ANALYSIS; PROTEIN BLOOD LEVEL; SAMPLE SIZE;

EID: 16244414875     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2004.09.003     Document Type: Article

References (16)

1. K. Ancolio, C. Dumanchin, H. Barelli, J.M. Warter, A. Brice, and D. Campion Unusual phenotypic alteration of beta amyloid precursor protein (beta-APP) maturation by a new Val-715>Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 96 1999 119 124
2. D. Selkoe Normal and abnormal biology of the β amyloid precursor protein Annu. Rev. Neurosci. 17 1994 489 517
3. C. Russo, S. Salis, V. Dolcini, V. Venezia, X.H. Song, and J.K. Teller Identification of amino-terminally and phosphotyrosine-modified carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain Neurobiol. Dis. 8 2001 173 180
4. N. Schupf, B. Patel, W. Silverman, W.B. Zigman, N. Zhong, and B. Tycko Elevated plasma amyloid β-peptide 1-42 and onset of dementia in adults with Down syndrome Neuro Lett. 301 2001 199 203
5. P.D. Mehta, A.J. Dalton, S.P. Mehta, K. Soo-Kim, E.A. Sersen, and H.M. Wisniewski Increased plasma amyloid β 1-42 levels in Down syndrome Neuro Lett. 241 1998 13 16
6. S. Fisher, J.D. Gearhart, and M.L. Oster-Granite Expression of the amyloid precursor protein gene in mouse oocytes and embryos Proc. Natl. Acad. Sci. U. S. A. 88 1991 1779 1782
7. H. Okado, and H. Okamoto A Xenopus homologue of the human beta-amyloid precursor protein: developmental regulation of its gene expression Biochem. Biophys. Res. Commun. 189 1992 1561 1568
8. Y. Hayashi, K. Kashiwagi, J. Ohta, M. Nakajima, T. Kawashima, and K. Yoshikawa Alzhemier amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain Biochem. Biophys. Res. Commun. 205 1994 936 943
9. W. Araki, N. Kitaguchi, Y. Tokushima, K. Ishii, H. Aratake, and S. Shimohama Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture Biochem. Biophys. Res. Commun. 181 1991 265 271
10. K. Yoshikawa, T. Aizawa, and Y. Hayashi Degeneration in vitro of post-mitotic neurons overexpressing the Alzheimer amyloid protein precursor Nature 359 1992 64 67
11. S. Narindrasorasak, D. Lowery, P. Gonzalez-DeWhitt, R.A. Poorman, B. Greenberg, and R. Kisilevsky High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan J. Biol. Chem. 266 1991 12878 12883
12. J.K. Teller, C. Russo, L.M. DeBusk, G. Angelini, D. Zaccheo, and F. Dagna-Bricarelli Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome Nat. Med. 2 1996 31 32
13. Y. Arai, A. Suzuki, M. Mizuguchi, and S. Takashima Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains Brain Dev. 19 1997 290 294
14. P.D. Mehta, S.P. Mehta, B. Fedor, B.A. Patrick, M. Emmerling, and A.J. Dalton Plasma amyloid β protein 1-42 levels are increased in old Down syndrome but not in young Down syndrome Neuro Lett. 342 2003 155 158
15. F. Bard, C. Cannon, R. Barbour, R.L. Burke, D. Games, and H. Grajeda Peripherally administered antibodies against amyloid β peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat. Med. 6 2000 916 919
16. Y. Matsuoka, M. Saito, J. LaFrancois, M. Saito, K. Gaynor, and V. Olm Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid J. Neurosci. 23 2003 29 33